RESEARCHER PROFILE

Colin C. Collins

← Back to University of British Columbia

C

University of British Columbia

Prostate Cancer Treatment and ResearchCancer Genomics and DiagnosticsChromatin Remodeling and CancerProstate Cancer Diagnosis and TreatmentGenomic variations and chromosomal abnormalities

Colin C. Collins works in Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics, Chromatin Remodeling and Cancer, Prostate Cancer Diagnosis and Treatment, Genomic variations and chromosomal abnormalities. Recorded institutional associations include University of British Columbia, Vancouver Prostate Centre.

704Publications
41,483Citations
89H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. The repertoire of mutational signatures in human cancer

    2020 · 3,468 citations

  2. Pan-cancer analysis of whole genomes

    2020 · 3,054 citations

  3. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

    1998 · 2,240 citations

  4. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4.

    1988 · 1,330 citations

  5. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1

    1997 · 1,284 citations

  6. PIK3CA is implicated as an oncogene in ovarian cancer

    1999 · 1,155 citations

  7. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis

    1998 · 1,123 citations

  8. The evolutionary history of 2,658 cancers

    2020 · 1,046 citations

  9. Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

    2011 · 999 citations

  10. Patterns of somatic structural variation in human cancer genomes

    2020 · 866 citations

  11. Chromosome aberrations in solid tumors

    2003 · 811 citations

  12. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing

    2020 · 713 citations

  13. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

    2020 · 602 citations

  14. Genomic hallmarks of localized, non-indolent prostate cancer

    2017 · 600 citations

  15. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene

    2000 · 590 citations

  16. Widespread and Functional RNA Circularization in Localized Prostate Cancer

    2019 · 544 citations

  17. Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer

    2015 · 478 citations

  18. Spatial genomic heterogeneity within localized, multifocal prostate cancer

    2015 · 477 citations

  19. Comprehensive molecular characterization of mitochondrial genomes in human cancers

    2020 · 465 citations

  20. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition

    2020 · 449 citations

  21. TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

    2007 · 426 citations

  22. The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer

    2016 · 418 citations

  23. MOLI: multi-omics late integration with deep neural networks for drug response prediction

    2019 · 413 citations

  24. Genomic basis for RNA alterations in cancer

    2020 · 393 citations

  25. The landscape of viral associations in human cancers

    2020 · 382 citations

← Return to the university profile